{"id":4560,"date":"2025-12-04T06:37:40","date_gmt":"2025-12-04T06:37:40","guid":{"rendered":"https:\/\/uiplonline.com\/abl-wordpress\/?p=4560"},"modified":"2026-04-20T07:22:50","modified_gmt":"2026-04-20T07:22:50","slug":"redefining-infectious-disease-detection-with-multiplex-pcr-and-syndromic-panels","status":"publish","type":"post","link":"https:\/\/www.abdoslifesciences.com\/fr\/redefining-infectious-disease-detection-with-multiplex-pcr-and-syndromic-panels\/","title":{"rendered":"Red\u00e9finir la d\u00e9tection des maladies infectieuses gr\u00e2ce \u00e0 la PCR multiplex et aux panels syndromiques\u00a0"},"content":{"rendered":"

Infectious diseases are becoming increasingly complex, with patients often showing overlapping symptoms that make accurate diagnosis difficult. Traditional methods that detect one pathogen at a time are no longer sufficient in today\u2019s fast evolving clinical landscape. There is a growing need for diagnostic tools that can identify multiple pathogens simultaneously, providing rapid and precise results. Modern microbiology technologies, such as multiplex PCR and syndromic testing panels, meet this need by enabling clinicians to detect several infectious agents in a single test, offering faster, more accurate diagnoses and improving patient outcomes. <\/p>\n\n\n\n

Multiplex PCR & Syndromic Testing Panels<\/strong> <\/p>\n\n\n\n

The multiplex polymerase chain reaction (Multiplex PCR) refers to the use of PCR to amplify several different DNA sequences simultaneously using multiple primers in one assay and one amplification program for all amplicons. By targeting multiple sequences at once, the information is gained from a single assay, reduces the requirement of several tubes and several run times and reagents and provides precise information compared to running multiple separate PCR reactions. <\/p>\n\n\n\n

Syndromic testing panels are multiplex molecular tests that use a single patient sample to rapidly identify multiple potential pathogens and resistance genes simultaneously. They are designed to diagnose infections with overlapping symptoms, like respiratory or gastrointestinal illnesses, by testing for many different bacteria, viruses, fungi, and parasites at once. This approach reduces the time to diagnosis, and helps healthcare providers make faster, more appropriate treatment decisions compared to traditional, single-organism testing. Syndromic diagnostic panels are now commercially available to aid in the diagnosis of common, serious infections that affect the bloodstream, respiratory, gastrointestinal, and central nervous systems. (1) <\/p>\n\n\n\n

Clinical Evaluation & Impact on Patient Care:<\/strong> <\/p>\n\n\n\n

In a recent clinical evaluation, the performance of four multiplex real-time PCR panels designed to detect infectious agents directly from blood, cerebrospinal fluid (CSF), respiratory, and stool samples were analysed. This panel was tested on infected sample of 1,929 patients and results were compared with traditional laboratory methods such as culture and standard PCR and in result a high diagnostic accuracy demonstrated with multiplex PCR Panels, confirming the efficiency of the multiplex PCR. (2) <\/p>\n\n\n\n